表紙
市場調查報告書

心臟去顫器的全球市場:各終端用戶、產品、地理的成長率、趨勢及預測(2018年∼2023年)

Defibrillator Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 659348
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
Back to Top
心臟去顫器的全球市場:各終端用戶、產品、地理的成長率、趨勢及預測(2018年∼2023年) Defibrillator Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年03月01日內容資訊: 英文 110 Pages
簡介

全球心臟去顫器市場,預計從2018年到2023年的預測期間內,以6.5%的年複合成長率成長。心臟去顫器,是對於有心室顫動、心律失常,及無脈性心室心搏過速等性命相關狀態的患者的心臟,幫助給予治療上的電擊的救命器具。美國,每年約有30萬人於院外發生心臟麻痺。已開發國家的政府輔助政策,與心臟去顫器的可用性與獲取性提高,更加促進在預測期間內的市場成長的可能性。

本報告提供全球心臟去顫器市場調查,整體市場趨勢,各產品、地區的詳細趨勢,市場成長的影響要素分析,競爭情形,主要企業簡介等,總括性彙整。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要預測

第5章 市場概要

  • 目前市場方案
  • 開發平台分析
  • 波特的五力分析
    • 供應商談判力
    • 消費者談判力
    • 新加入廠商的威脅
    • 替代產品與服務的威脅
    • 產業內的競爭
  • 法規方案

第6章 成長要素,阻礙因素,機會,課題分析(DROC)

  • 市場成長要素
    • 心臟血管疾病的罹患率增加
    • 心臟去顫器的技術進步
    • 心臟去顫器的訓練和宣導活動
  • 市場阻礙因素
    • 成本高的心臟去顫器
    • 嚴格的法規結構
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各終端用戶
    • 醫院
    • 急救醫療
    • 居家醫療
    • 其他
  • 各產品
    • 置入式除顫器(ICD)
    • 體外電擊器(ED)
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • M&A分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要業者

  • Boston Scientific Corporation
  • Cardiac Science
  • Defibtech LLC
  • Koninklijke Philips NV
  • LivaNova PLC
  • Medtronic
  • 日本光電
  • Physio-Control Inc.
  • Abbott (St. Jude Medical, LLC)
  • ZOLL Medical Corporation

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 61708

Market Overview

The growth of the defibrillator market can be attributed to factors such as technological advancements in the field of defibrillators and training and awareness programs for defibrillators. According to the American Heart Association's research program, cardiovascular diseases are listed as the primary cause of deaths, and accounted for nearly 836,546 deaths in the United States. The deaths related to cardiovascular diseases are higher when compared to deaths related to all forms of cancer and chronic lower respiratory diseases combined. As per the American Heart Association, cardiovascular disease is the leading cause of death, globally, accounting for more than 17.9 million deaths per year in 2015, a number that is expected to grow to more than 23.6 million by 2030. Hence, the increase in prevalence of cardiovascular diseases is expected to drive the market growth.

Scope of the Report

Defibrillator is a life-saving device that helps deliver a therapeutic shock to a patient's heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. In the United States, approximately 300,000 out-of-hospital cardiac arrests occur each year. Supportive government policies in developed countries may help increase the availability and access of defibrillators, which will likely further boost the market growth over the forecast period.

Key Market Trends

Implantable Cardioverter Defibrillator(ICD) Spearheaded the Defibrillator Market

The implantable cardioverter defibrillator (ICD) segment accounted for the largest share in the global market. The ICDs are of three major types, namely transvenous ICDs, subcutaneous ICDs, and CRT with pacemaker and ICD function. The transvenous and subcutaneos ICDs are expected to exhibit the fastest growth rate over the forecast period, owing to the rising technological advancements, increasing R&D, and benefits associated with these ICDs. The overall ICD segment contributes for the largest market share, owing to the rising integration of multiple technological capabilities in a single device, such as defibrillators and pacemakers. In addition, the efficacy of these devices to manage arhythmias for a prolonged period is expected to drive the segment growth over the forecast period.

North America Dominated the Global Defibrillator Market

Cardiovascular diseases, listed as the underlying cause of death, account for nearly 836,546 deaths (about 1 of every 3 deaths) in the United States. Thus, the increasing prevalence of cardiovascular diseases in the region is expected to drive the growth of this market over the forecast period. In 2017, the Department of Health and Human Services (HHS), along with a number of public and private partners, launched the Million Hearts initiative that aims to prevent one million heart attacks and strokes. All the aforementioned factors are expected to boost the market growth.

Competitive Landscape

The major players operating in the defibrillators market are Boston Scientific Corporation, Koninklijke Philips NV., Medtronic, Nihon Kohden Corporation, and Abbott Laboratories. The key strategies adopted by the major market players are acquisitions and mergers, new product developments, geographical expansions, and enhanced marketing strategies.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases
    • 4.2.2 Technological Advancements in the Field of Defibrillators
    • 4.2.3 Training and Awareness Programs about Defibrillators
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Defibrilators
    • 4.3.2 Stringent Regulatory Framework
  • 4.4 Industry Attractiveness Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Implantable Cardioverter Defibrillator
      • 5.1.1.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
      • 5.1.1.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
      • 5.1.1.3 CRT with Pacemaker and ICD Function (CRT-D)
    • 5.1.2 External Defibrillator (ED)
      • 5.1.2.1 Automated External Defibrillator (AEDs)
      • 5.1.2.1.1 Semi-automated External Defibrillators
      • 5.1.2.1.2 Fully-automated External Defibrillators
      • 5.1.2.2 Manual External Defibrillator
      • 5.1.2.3 Wearable Cardioverter Defibrillators (WCDs)
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Emergency Care
    • 5.2.3 Home Care
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 United Kingdom
      • 5.3.2.2 Germany
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cardiac Science Corporation
    • 6.1.4 Defibtech LLC
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 LivaNova PLC
    • 6.1.7 Medtronic plc.
    • 6.1.8 NIHON KOHDEN CORPORATION
    • 6.1.9 Physio-Control Inc.
    • 6.1.10 ZOLL Medical Corporation

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top